Pancreatic cancer therapies are evolving market to reach $9.65B by 2033 thanks to better diagnostics, new drug development, and R&D funding.
With advanced treatment methods and a rising cancer burden, the pancreatic cancer market is projected to grow to $9.65B by 2033 globally.